Treatment with indoxyl sulfate for 48 hours produced a concentration-dependent decrease in CYP3A4 mRNA expression as the concentration was increased from those measured in healthy controls to concentrations in patients with CKD (IC50 = 113.0 ± 3.5 μM) (Fig. 5B). The gene discussed is CYP3A4; the disease is chronic kidney disease.